Showing results (1161-1170 of 1,465) with videos related to
Sort By:
Pageof 147
Clinics in Liver Disease|June 22, 2011
The global epidemiology of hepatocellular carcinoma: present and futureKatherine A McGlynn, W Thomas LondonClinics in Liver Disease|June 22, 2011
Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinomaAsma Siddique, Kris V KowdleyClinics in Liver Disease|June 22, 2011
The role of oncogenic viruses in the pathogenesis of hepatocellular carcinomaRomy Zemel, Assaf Issachar, Ran Tur-KaspaClinics in Liver Disease|November 24, 2015
Utility of Noninvasive Markers of Fibrosis in Cholestatic Liver DiseasesChristophe CorpechotClinics in Liver Disease|October 16, 2015
Meet the Classes of Directly Acting Antiviral Agents: Strengths and WeaknessesKristina R Chacko, Paul J GaglioClinics in Liver Disease|October 16, 2015
Mechanisms of Virologic Failure with Direct-Acting Antivirals in Hepatitis C and Strategies for RetreatmentVanessa Costilla, Neha Mathur, Julio A GutierrezClinics in Liver Disease|October 16, 2015
Current Management of Hepatitis C Virus: Regimens for Peri-Liver Transplant PatientsVarun Saxena, Norah TerraultClinics in Liver Disease|April 12, 2016
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the WorldMehmet Sayiner, Aaron Koenig, Linda Henry, et al.Clinics in Liver Disease|April 12, 2016
Nonalcoholic Fatty Liver Disease and the Gut MicrobiomeJerome Boursier, Anna Mae DiehlClinics in Liver Disease|April 12, 2016
Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver DiseaseVaishali Patel, Arun J Sanyal, Richard SterlingPageof 147